Beyond the Blockbuster : Finding the Next Profit zone in Pharmaceuticals Through Business Design Thinking
- Topics:
- Modeling
- Tags:
- Blockbuster,
- Blockbuster Inc.,
- Management,
- Marsh & McLennan Companies,
- Pharmaceutical Company,
- Strategy
- Source:
- Marsh & McLennan Companies
FREE Registration is required
Overview: The rapid growth of pharma companies in the 1990s was driven by a ‘blockbuster’ model. This model is under pressure: Slowing scientific innovation and rising development costs combine with prescribers, payors and patients becoming tougher customers. But investor expectations remain high as much of the value of companies is still derived from products yet to be launched. Finding a way through this situation calls for some deep thinking around new business models and different ‘customer’ relationships. The approach is to identify new or adapted Business Designs that make money in distinctive ways that enable senior leaders to frame the questions they need to ask to find the profit zones of the future. This approach shows that some company strategies are beginning to move away from the traditional blockbuster model and are, in fact, becoming very different.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 166KB | Date: Jan 2003 | Pages: 20
